Results 1-8 of 8 (Search time: 0.002 seconds).
Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link | |
---|---|---|---|---|---|---|---|
1 | 2023 | Broadly neutralizing antibodies against Omicron variants of SARS-CoV-2 derived from mRNA-lipid nanoparticle-immunized mice | Ruei-Min Lu ; Kang-Hao Liang; Hsiao-Ling Chiang; Fu-Fei Hs; Hsiu-Ting Lin; Wan-Yu Chen; Feng-Yi Ke; Monika Kumari; Yu-Chi Chou ; Mi-Hua Tao ; Yi-Ling Lin ; Han-Chung Wu | Heliyon 9(5), e15587 | |||
2 | 2022 | An efficient approach for SARS-CoV-2 monoclonal antibody production via modified mRNA-LNP immunization | Hsu, FF; Liang, KH; Kumari, M; Chen, WY; Lin, HT; Cheng, CM; Tao, MH ; Wu, HC | International Journal of Pharmaceutics 627:122256, 1-10 | |||
3 | 2022 | A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies | Kumari, Monika; Lu, Ruei-Min ; Li, Mu-Chun; Huang, Jhih-Liang; Hsu, Fu-Fei; Ko, Shih-Han; Ke, Feng-Yi; Su, Shih-Chieh; Liang, Kang-Hao; Yuan, Joyce Pei-Yi; Chiang, Hsiao-Ling; Sun, Cheng-Pu; Lee, I.-Jung; Li, Wen-Shan ; Hsieh, Hsing-Pang ; Tao, Mi-Hua ; Wu, Han-Chung | Journal of Biomedical Science 29(1), 68 | |||
4 | 2022 | A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants | Lee, I-Jung; Sun, Cheng-Pu ; Wu, Ping-Yi; Lan, Yu-Hua; Wang, I-Hsuan ; Liu, Wen-Chun ; Yuan, Joyce, Pei-Yi; Chang, Yu-Wei; Tseng, Sheng-Che; Tsung, Szu-I; Chou, Yu-Chi ; Kumari, Monika; Lin, Yin-Shiou; Chen, Hui-Feng; Chen, Tsung-Yen; Lin, Chih-Chao; Chiu, Chi-Wen; Hsieh, Chung-Hsuan; Chuang, Cheng-Ying; Cheng, Chao-Min; Lin, Hsiu-Ting; Chen, Wan-Yu; Hsu, Fu-Fei; Hong, Ming-Hsiang; Liao, Chun-Che ; Chang, Chih-Shin; Liang, Jian-Jong; Ma, Hsiu-Hua; Chiang, Ming-Tsai; Liao, Hsin-Ni; Ko, Hui-Ying; Chen, Liang-Yu; Ko, Yi-An; Yu, Pei-Yu; Yang, Tzu-Jing; Chiang, Po-Cheng; Hsu, Shang-Te ; Lin, Yi-Ling ; Lee, Chong-Chou; Wu, Han-Chung ; Tao, Mi-Hua | Journal of Biomedical Science 29(1), 49 | |||
5 | 2022 | Omicron-specific mRNA vaccine induced potent neutralizing antibody against Omicron but not other SARS-CoV-2 variants | Lee, IJ; Sun, CP; Wu, PY; Lan, YH; Wang, IH ; Liu, WC ; Tseng, SC; Tsung, SI; Chou, YC ; Kumari, M; Chang, YW; Chen, HF; Lin, YS; Chen, TY; Chiu, CW; Hsieh, CH; Chuang, CY; Lin, CC; Cheng, CM; Lin, HT; Chen, WY; Chiang, PC; Lee, CC; Liao, JC; Wu, HC ; Tao, MH | BioRxiv | |||
6 | 2021 | Antibody cocktail effective against variants of SARS-CoV-2 | Liang, Kang-Hao; Chiang, Pao-Yin; Ko, Shih-Han; Chou, Yu-Chi ; Lu, Ruei-Min ; Lin, Hsiu-Ting; Chen, Wan-Yu; Lin, Yi-Ling ; Tao, Mi-Hua ; Jan, Jia-Tsrong ; Wu, Han-Chung | Journal of biomedical science 28, 80 | |||
7 | 2021 | Structure-guided Antibody Cocktail for Prevention and Treatment of COVID-19 | Shih-Chieh Su; Tzu-Jing Yang; Pei-Yu Yu; Kang-Hao Liang; Wan-Yu Chen; Chun-Wei Yang; Hsiu-Ting Lin; Meng-Jhe Wang; Ruei-Min Lu ; Hsien-Cheng Tso; Meng-Jhe Chung; Tzung-Yang Hsieh; Yu-Ling Chang; Shin-Chang Lin; Fang-Yu Hsu; Feng-Yi Ke; Yi-Hsuan Wu; Yu-Chyi Hwang; I-Ju Liu; Jian-Jong Liang; Chun-Che Liao ; Hui-Ying Ko; Cheng-Pu Sun ; Ping-Yi Wu; Jia-Tsrong Jan ; Yuan-Chih Chang ; Yi-Ling Lin ; Mi-Hua Tao ; Shang-Te Danny Hsu ; Han-Chung Wu | PLOS Pathogens 17(10), e1009704 | |||
8 | 2021 | Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19 | Sun, Cheng-Pu ; Jan, Jia-Tsrong ; Wang, I-Hsuan ; Ma, Hsiu-Hua; Ko, Hui-Ying; Wu, Ping-Yi; Kuo, Tzu-Jiun; Liao, Hsin-Ni; Lan, Yu-Hua; Sie, Zong-Lin; Chen, Yen-Hui ; Ko, Yi-An; Liao, Chun-Che ; Chen, Liang-Yu; Lee, I-Jung; Tsung, Szu-I; Lai, Yun-Ju; Chiang, Ming-Tsai; Liang, Jian-Jong; Liu, Wen-Chun ; Wang, Jing-Rong; Yuan, Joyce Pei-Yi; Lin, Yin-Shiou; Tsai, Yi-Ching; Hsieh, Shie-Liang ; Li, Chia-Wei ; Wu, Han-Chung ; Ko, Tai-Ming; Lin, Yi-Ling ; Tao, Mi-Hua | PLoS pathogens 17(8), e1009758 |